Sasahara, A.A. , Cannilla, J.E., Belko, J.S., et al.: Urokinase therapy in clinical pulmonary embolism. N. Engl. J. Med., 277: 1168, 1967 .
2.
Sasahara, A.A. , Hyers, T.M., Cole, C.M., et al.: The urokinase pulmonary embolism trial. A national cooperative study. Circulation, 47 (Suppl. 2): 1, 1973.
3.
Urokinase-streptokinase pulmonary embolism trial: Phase II results. JAMA,229: 1606, 1974.
4.
Sharma, G.V.R.K. , Burleson, V.A., Sasahara, A.A.: Effect of thrombolytic therapy on pulmonary capillary blood volume in patients with pulmonary embolism. N. Engl. J. Med., 303: 842, 1980.
5.
Roughton, F.J.W. , Forster, R.E.: Relative importance of diffusion and clinical reaction rates in determining rate of exchange of gases in the human lung with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J. Appl. Physiol. , 2: 290, 1957.
6.
McIntyre, K.M. , Sasahara, A.A.: The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am. J. Cardiol., 28: 288, 1971.
